BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 7671460)

  • 1. The epidermal growth factor receptor in glioblastoma: genomic amplification, protein expression, and patient survival data in a therapeutic trial.
    Schober R; Bilzer T; Waha A; Reifenberger G; Wechsler W; von Deimling A; Wiestler OD; Westphal M; Kemshead JT; Vega F
    Clin Neuropathol; 1995; 14(3):169-74. PubMed ID: 7671460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of epidermal growth factor receptor and human epidermal growth factor receptor 2 activating mutations in lung adenocarcinoma by high-resolution melting amplicon analysis: correlation with gene copy number, protein expression, and hormone receptor expression.
    Willmore-Payne C; Holden JA; Layfield LJ
    Hum Pathol; 2006 Jun; 37(6):755-63. PubMed ID: 16733218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemically determined total epidermal growth factor receptor levels not of prognostic value in newly diagnosed glioblastoma multiforme: report from the Radiation Therapy Oncology Group.
    Chakravarti A; Seiferheld W; Tu X; Wang H; Zhang HZ; Ang KK; Hammond E; Curran W; Mehta M
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):318-27. PubMed ID: 15890570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme.
    Shinojima N; Tada K; Shiraishi S; Kamiryo T; Kochi M; Nakamura H; Makino K; Saya H; Hirano H; Kuratsu J; Oka K; Ishimaru Y; Ushio Y
    Cancer Res; 2003 Oct; 63(20):6962-70. PubMed ID: 14583498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging characteristics predict epidermal growth factor receptor amplification status in glioblastoma.
    Aghi M; Gaviani P; Henson JW; Batchelor TT; Louis DN; Barker FG
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8600-5. PubMed ID: 16361543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal growth factor receptor in glioblastomas: correlation between gene copy number and protein expression.
    Coulibaly B; Nanni I; Quilichini B; Gaudart J; Metellus P; Fina F; Boucard C; Chinot O; Ouafik L; Figarella-Branger D
    Hum Pathol; 2010 Jun; 41(6):815-23. PubMed ID: 20303140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amplification of the epidermal growth factor receptor in astrocytic tumours by chromogenic in situ hybridization: association with clinicopathological features and patient survival.
    Järvelä S; Helin H; Haapasalo J; Järvelä T; Junttila TT; Elenius K; Tanner M; Haapasalo H; Isola J
    Neuropathol Appl Neurobiol; 2006 Aug; 32(4):441-50. PubMed ID: 16866989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amplification of the epidermal growth factor receptor gene in glioblastoma: an analysis of the relationship between genotype and phenotype by CISH method.
    Miyanaga T; Hirato J; Nakazato Y
    Neuropathology; 2008 Apr; 28(2):116-26. PubMed ID: 18021194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression of epidermal growth factor receptor and transforming growth factor alpha in renal cell carcinoma.
    Lager DJ; Slagel DD; Palechek PL
    Mod Pathol; 1994 Jun; 7(5):544-8. PubMed ID: 7937720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection pressures of TP53 mutation and microenvironmental location influence epidermal growth factor receptor gene amplification in human glioblastomas.
    Okada Y; Hurwitz EE; Esposito JM; Brower MA; Nutt CL; Louis DN
    Cancer Res; 2003 Jan; 63(2):413-6. PubMed ID: 12543796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor receptor amplification does not have prognostic significance in patients with glioblastoma multiforme.
    Quan AL; Barnett GH; Lee SY; Vogelbaum MA; Toms SA; Staugaitis SM; Prayson RA; Peereboom DM; Stevens GH; Cohen BH; Suh JH
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):695-703. PubMed ID: 15936158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and immunohistochemical evaluation of epidermal growth factor receptor and c-erb-B-2 gene product in transitional cell carcinomas of the urinary bladder: a study in Greek patients.
    Gorgoulis VG; Barbatis C; Poulias I; Karameris AM
    Mod Pathol; 1995 Sep; 8(7):758-64. PubMed ID: 8539234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical detection of epidermal growth factor receptor in human high-grade astrocytomas--a comparison between frozen- and paraffin sections.
    Torp SH; Bringedal K; Dalen A
    J Exp Clin Cancer Res; 2005 Mar; 24(1):89-92. PubMed ID: 15943037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein overexpression and gene amplification of epidermal growth factor receptor in nonsmall cell lung carcinomas. An immunohistochemical and fluorescence in situ hybridization study.
    Suzuki S; Dobashi Y; Sakurai H; Nishikawa K; Hanawa M; Ooi A
    Cancer; 2005 Mar; 103(6):1265-73. PubMed ID: 15712203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Color multiplex polymerase chain reaction for quantitative analysis of epidermal growth factor receptor genes in colorectal adenocarcinoma.
    Layfield LJ; Bernard PS; Goldstein NS
    J Surg Oncol; 2003 Aug; 83(4):227-31. PubMed ID: 12884235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibody 806 inhibits the growth of tumor xenografts expressing either the de2-7 or amplified epidermal growth factor receptor (EGFR) but not wild-type EGFR.
    Luwor RB; Johns TG; Murone C; Huang HJ; Cavenee WK; Ritter G; Old LJ; Burgess AW; Scott AM
    Cancer Res; 2001 Jul; 61(14):5355-61. PubMed ID: 11454674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic significance of epidermal growth factor receptor (EGFR), C-erbB-2, Ki-67 and PCNA expression in breast cancer.
    Ioachim E; Kamina S; Athanassiadou S; Agnantis NJ
    Anticancer Res; 1996; 16(5B):3141-7. PubMed ID: 8920782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein expression and gene amplification of epidermal growth factor receptor in thymomas.
    Ionescu DN; Sasatomi E; Cieply K; Nola M; Dacic S
    Cancer; 2005 Feb; 103(3):630-6. PubMed ID: 15630697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of chromosome 7, chromosome 10 and EGFR gene amplification in glioblastoma multiforme.
    Lopez-Gines C; Cerda-Nicolas M; Gil-Benso R; Pellin A; Lopez-Guerrero JA; Callaghan R; Benito R; Roldan P; Piquer J; Llacer J; Barbera J
    Clin Neuropathol; 2005; 24(5):209-18. PubMed ID: 16167544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The activation of ERK1/2 MAP kinases in glioblastoma pathobiology and its relationship with EGFR amplification.
    Lopez-Gines C; Gil-Benso R; Benito R; Mata M; Pereda J; Sastre J; Roldan P; Gonzalez-Darder J; Cerdá-Nicolás M
    Neuropathology; 2008 Oct; 28(5):507-15. PubMed ID: 18410277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.